Categories Earnings, Industrials

Halliburton’s Q4 results beat estimates

Halliburton Company (NYSE: HAL) reported better-than-expected revenue and earnings for the fourth quarter of 2019. Shares were up 1.9% in premarket hours on Tuesday.  

Total revenue of $5.2 billion was down 11% from the same period a year ago but came ahead of estimates of $5.11 billion.

Halliburton beats Q4 2019 revenue and earnings estimates

The company reported a net loss of $1.6 billion, or $1.88 per share in the quarter, compared to a net income of $664 million, or $0.76 per share, last year, mainly due to a $2.2 billion impairment charge associated with cost structure adjustments. Adjusted EPS totaled $0.32, beating forecasts of $0.29.

CEO Jeff Miller stated, “In 2020, we expect our international growth to continue. Increased activity, disciplined capital allocation, pricing improvements, and our ability to compete for a larger share of high-margin services should lead to improvement in our international margins in 2020.”

Completion and Production revenue fell 13% sequentially to $3.1 billion due mainly to reduced activity and pricing in multiple product service lines in North America land and reduced stimulation services in Latin America.

Also read: Netflix Q4 2019 Earnings Preview

Drilling and Evaluation revenue increased 4% sequentially, driven by increased activity in all product service lines in Middle East/Asia, along with increased drilling activity in Europe/Africa/CIS and year-end software sales globally.  

Revenue in North America dropped 21% sequentially, mainly due to reduced activity and pricing in North America land. International revenue rose 10% sequentially, helped by increased activity in multiple product service lines in Middle East/Asia and increased well construction activity in the North Sea.

Revenue in Latin America fell 2% sequentially while revenue in the Europe/Africa/CIS and Middle East/Asia regions grew 6% and 19%, respectively.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top